Pharmacosmos A/S
Quick facts
Marketed products
- ferrous fumarate with ascorbic acid · Hematology
Ferrous fumarate provides bioavailable iron for hemoglobin synthesis, while ascorbic acid enhances iron absorption by maintaining it in the reduced ferrous state. - Monofer · Other
Phase 3 pipeline
- Iron isomaltoside/ferric derisomaltose · Hematology
Iron isomaltoside delivers ferric iron complexed with isomaltoside, a carbohydrate polymer, to replenish iron stores and treat iron deficiency anemia. - Iron oligosaccharide · Hematology
Iron oligosaccharide delivers iron in a carbohydrate-stabilized form that is absorbed through the gastrointestinal tract to replenish iron stores and treat iron deficiency.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Pharmacosmos A/S
What are Pharmacosmos A/S's marketed drugs?
Top marketed products include ferrous fumarate with ascorbic acid, Monofer.
What is Pharmacosmos A/S's pipeline?
Pharmacosmos A/S has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Iron isomaltoside/ferric derisomaltose, Iron oligosaccharide.
Related
- ferrous fumarate with ascorbic acid · Hematology
- Monofer · Other
- Sector hub: All tracked pharma companies